Literature DB >> 1920121

Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.

O Nikodijević1, R Sarges, J W Daly, K A Jacobson.   

Abstract

The locomotor effects in mice of selective A1 and A2 adenosine agonists, antagonists and combinations of agonists were investigated using a computerized activity monitor. The A2-selective agonist 2-[(2-aminoethylamino)carbonylethylphenylethylamino[-5'-N- ethylcarboxamidoadenosine (APEC), an amine derivative of 2-(carboxyethylphenylethylamino)adenosine-5'-carboxamide, was a more potent locomotor depressant than its amide conjugates. The rank order of potency after i.p. injection for adenosine agonists was 5'-N-ethylcarboxamidoadenosine (NECA) (ED50, 5.8 nmol/kg) greater than APEC (ED50, 25 nmol/kg) greater than N6-cyclohexyladenosine (CHA) (ED50, 270 nmol/kg). An A1-selective, centrally acting, adenosine antagonist, 8-cyclopentyltheophylline (10 mg/kg), completely reversed the locomotor depressant effects of CHA (A1-selective) and NECA (nonselective) at doses of agonists as high as twice the ED50, and shifted the dose-response curves to the right, suggesting a primary involvement of A1 receptors. 8-cyclopentyltheophylline did not affect the depressant effects of APEC at the ED50, consistent with the A2-selectivity of APEC. The locomotor effects of APEC and CHA were completely reversed by theophylline, but not by the peripherally active 8-p-sulfophenyltheophylline, indicating central action of the adenosine agonists. The depressant effects of APEC, but not of NECA or CHA, were reversed significantly by an A2-selective adenosine receptor antagonist, 4-amino-8-chloro-1-phenyl-[1,2,4]triazol[4,3-a]quinoxaline. Low or subthreshold doses of CHA potentiated the depressant effects of APEC. A subthreshold dose of CHA did not alter the depressant effect of NECA, whereas a subthreshold dose of APEC increased the depressant effects of low doses of NECA. Thus, it appears that A1- and A2-selective adenosine agonists have separate central depressant effects, which can be potentiative.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920121      PMCID: PMC3425643     

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  34 in total

Review 1.  Adenosine as a neuromodulator.

Authors:  S H Snyder
Journal:  Annu Rev Neurosci       Date:  1985       Impact factor: 12.449

2.  Automated measurement of multivariate locomotor behavior in rodents.

Authors:  P R Sanberg; S H Hagenmeyer; M A Henault
Journal:  Neurobehav Toxicol Teratol       Date:  1985 Jan-Feb

3.  Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat.

Authors:  R A Barraco; A K Aggarwal; J W Phillis; M A Moron; P H Wu
Journal:  Neurosci Lett       Date:  1984-07-27       Impact factor: 3.046

4.  Stereoselective behavioral effects of N6-phenylisopropyl-adenosine and antagonism by caffeine.

Authors:  S R Goldberg; J A Prada; J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine.

Authors:  R A Barraco; V L Coffin; H J Altman; J W Phillis
Journal:  Brain Res       Date:  1983-08-08       Impact factor: 3.252

6.  Interactions in the behavioral effects of methylxanthines and adenosine derivatives.

Authors:  J J Katims; Z Annau; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

7.  Behavioural sensitivity to PIA in selectively bred mice is related to a number of A1 adenosine receptors but not to cyclic AMP accumulation in brain slices.

Authors:  B B Fredholm; N R Zahniser; G R Weiner; W R Proctor; T V Dunwiddie
Journal:  Eur J Pharmacol       Date:  1985-04-23       Impact factor: 4.432

8.  Behavioral effects of caffeine, (-)N-((R)-1-methyl-2-phenylethyl)-adenosine (PIA), and their combination in the mouse.

Authors:  J R Glowa; E Sobel; S Malaspina; P B Dews
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Adenosine receptors and behavioral actions of methylxanthines.

Authors:  S H Snyder; J J Katims; Z Annau; R F Bruns; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  In vivo behavioral assessment of central nervous system purinergic receptors.

Authors:  G G Yarbrough; J C McGuffin-Clineschmidt
Journal:  Eur J Pharmacol       Date:  1981-12-03       Impact factor: 4.432

View more
  30 in total

1.  A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors.

Authors:  Katerina Antoniou; Zeta Papadopoulou-Daifoti; Thomas Hyphantis; Georgia Papathanasiou; Efstathios Bekris; Marios Marselos; Leigh Panlilio; Christa E Müller; Steven R Goldberg; Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

2.  Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Authors:  K A Jacobson; G L Stiles; X D Ji
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

3.  2-[2-[4-[2-[2-[ 1,3-Dihydro- 1,1-bis (4-hydroxyphenyl)-3-oxo-5-isobenzofuranthioureidyl]ethylaminocarbonyl]ethyl]phenyl] ethylamino]-5'-N-ethylcarboxamidoadenosine (FITC-APEC): A Fluorescent Ligand For A2a-Adenosine Receptors.

Authors:  R Tyler McCabe; Phil Skolnick; Kenneth A Jacobson
Journal:  J Fluoresc       Date:  1992-12       Impact factor: 2.217

4.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

5.  Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs.

Authors:  G B Kaplan; M T Sears
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

6.  The role of adenosine receptors in the central action of caffeine.

Authors:  John W Daly; Dan Shi; Olga Nikodijevic; Kenneth A Jacobson
Journal:  Pharmacopsychoecologia       Date:  1994

7.  The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.

Authors:  M El Yacoubi; C Ledent; J F Ménard; M Parmentier; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 8.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

9.  Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.

Authors:  K A Jacobson; C Gallo-Rodriguez; N Melman; B Fischer; M Maillard; A van Bergen; P J van Galen; Y Karton
Journal:  J Med Chem       Date:  1993-05-14       Impact factor: 7.446

10.  Effects of purine analogues on spontaneous alternation in mice.

Authors:  N Hooper; C Fraser; T W Stone
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.